Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of $11.11 million. The enterprise value is $33.62 million.
| Market Cap | 11.11M |
| Enterprise Value | 33.62M |
Important Dates
The last earnings date was Tuesday, February 20, 2024, after market close.
| Earnings Date | Feb 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 9.26 million shares outstanding. The number of shares has increased by 3.32% in one year.
| Shares Outstanding | 9.26M |
| Shares Change (YoY) | +3.32% |
| Shares Change (QoQ) | +2.09% |
| Owned by Insiders (%) | 14.81% |
| Owned by Institutions (%) | 3.93% |
| Float | 7.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.96 |
| Forward PS | 3.43 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21
| Current Ratio | 0.21 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -246.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $211,409 |
| Profits Per Employee | -$279,751 |
| Employee Count | 55 |
| Asset Turnover | 1.86 |
| Inventory Turnover | 2.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.25% in the last 52 weeks. The beta is 1.54, so Biotricity's price volatility has been higher than the market average.
| Beta (1Y) | 1.54 |
| 52-Week Price Change | -75.25% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 46.38 |
| Average Volume (30 Days) | 86,219 |
Short Selling Information
The latest short interest is 358,438, so 3.87% of the outstanding shares have been sold short.
| Short Interest | 358,438 |
| Short Previous Month | 204,974 |
| Short % of Shares Out | 3.87% |
| Short % of Float | 4.55% |
| Short Ratio (days to cover) | 2.26 |
Income Statement
In the last 12 months, Biotricity had revenue of $11.63 million and -$15.39 million in losses. Loss per share was -$1.75.
| Revenue | 11.63M |
| Gross Profit | 7.62M |
| Operating Income | -7.90M |
| Pretax Income | -14.58M |
| Net Income | -15.39M |
| EBITDA | -9.92M |
| EBIT | -10.54M |
| Loss Per Share | -$1.75 |
Balance Sheet
The company has $170,094 in cash and $22.59 million in debt, giving a net cash position of -$22.42 million or -$2.42 per share.
| Cash & Cash Equivalents | 170,094 |
| Total Debt | 22.59M |
| Net Cash | -22.42M |
| Net Cash Per Share | -$2.42 |
| Equity / Book Value | -27.76M |
| Book Value Per Share | -3.00 |
| Working Capital | -14.69M |
Cash Flow
| Operating Cash Flow | -7.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.41M |
| FCF Per Share | -$0.83 |
Margins
Gross margin is 65.52%, with operating and profit margins of -67.98% and -132.33%.
| Gross Margin | 65.52% |
| Operating Margin | -67.98% |
| Pretax Margin | -125.43% |
| Profit Margin | -132.33% |
| EBITDA Margin | -85.34% |
| EBIT Margin | -90.66% |
| FCF Margin | -63.70% |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.32% |
| Shareholder Yield | -3.32% |
| Earnings Yield | -137.34% |
| FCF Yield | -66.11% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
Biotricity has an Altman Z-Score of -38.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -38.64 |
| Piotroski F-Score | 4 |